The UK Medicines and Healthcare products Regulatory Agency (MHRA) decided in 2005 to withdraw co-proxamol from the market following advice from the Committee on Safety of Medicines (CSM) that co-proxamol is little more effective than paracetamol alone as an analgesic, but that it was associated with higher fatality rates if a drug overdose were intentionally or inadvertently taken. The decision provoked some outcry from long-term users of the drug.
- Suicide painkiller withdrawn. The Times (January 31, 2005).
- Painkiller scrapped over suicides. BBC News (January 31, 2005).
- Co-proxamol to be withdrawn from the market. Medicines and Healthcare products Regulatory Agency (31 January 2005).
- Withdrawal of co-proxamol. Medicines and Healthcare products Regulatory Agency (17 January 2007).
There is no pharmaceutical or device industry support for this site and we need your viewer supported Donations | Editorial Board | Governance | Licensing | Disclaimers | Avoid Plagiarism | Policies